Please ensure Javascript is enabled for purposes of website accessibility

3 Humongous Health-Care Stocks This Week

By Keith Speights – Mar 1, 2014 at 7:31AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Which health-care stocks sizzled this week? Find out in our weekly rankings.

Sure, it's still cold across most of the country. After all, the famous groundhog in Punxsutawney, Pa., did see his shadow in early February. According to the legend, that means we still have a few more weeks of winter. However, some health-care stocks are already generating so much heat you'd think it was summer.

One of these sizzling stocks announced terrific late-stage clinical results for a lead drug. Another scored an options licensing deal with a major pharmaceutical company. Our third big winner of the week benefited from a price target upgrade.

Which stocks made this week's most humongous list? Find out by watching the following slideshow.

Keith Speights and The Motley Fool have no position in any of the stocks mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.